Angola vs Panama: Cause of death, by non-communicable diseases, ages 15-59, male
Angola
38.7%
in 2021
Panama
39.0%
in 2021
Angola rank
141st
Panama rank
138th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Angola
- Panama
How they compare
Panama currently reports 39.0% against 38.7% in Angola, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Panama ahead.
Angola ranks 141st and Panama ranks 138th of 185 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Angola | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 32.8% | 38.3% | 5.5% | Panama |
| 2010s | 36.6% | 44.2% | 7.6% | Panama |
| 2020s | 39.3% | 37.4% | 1.9% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Angola or Panama?
- Panama, at 39.0% against 38.7% in Angola as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Angola and Panama?
- 0.3%, with Panama ahead.
- How many years of comparable data are there for Angola and Panama?
- 6 years are reported by both, from 2000 to 2021.
- How do Angola and Panama rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Angola ranks 141st and Panama ranks 138th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.